EMA Committee Recommends Approval of Eli Lilly Weight-Loss Pill
The European Medicines Agency's committee recommended approval of Eli Lilly's Foundayo, paving the way for a second oral weight-loss drug to win backing in the region after Novo Nordisk's Wegovy pill.
Story updates
10:24:50 AM UTC
SquawkNews
Eli Lilly's weight-loss pill wins EU drug regulator's backing
On Friday, a European Medicines Agency committee recommended approving Eli Lilly's NYSE:LLY weight-loss pill Foundayo. The recommendation could allow the region to back a second oral weight-loss drug, following Novo Nordisk's OMXCOP:NOVO_B Wegovy pill.